Cannabis for depression variability highlights why the same product can improve mood for one person and worsen it for another, and how to approach treatment more precisely.
Study: Clinical evidence review for Cannabidiol
This 2024 paper is a narrative review of cannabidiol, cannabis-derived products, regulation, pharmacology, and clinical use. It offers a useful overview of why purified CBD, commercial extracts, and broader cannabis products should not be treated as interchangeable. Its value is real, but it remains a narrative review, not a new trial, so its conclusions should be read as framing and synthesis rather than definitive proof.
How to Read a Cannabis Certificate of Analysis
A concept focused on COA interpretation, batch matching, dates, and practical consumer safety habits.
Neuroendocrine Tumor Treatment Abroad: Diagnosis and Care Options
[no_toc] Sponsored Content This article is a paid sponsored placement by Booking Health. CED Clinic did not provide medical review, clinical guidance, or editorial endorsement of any hospital, treatment program, or travel...
What This Lancet Review Really Says About Cannabinoids in Psychiatry
A new Lancet Psychiatry review examined 54 randomized trials of cannabinoids for mental disorders and substance use disorders, and the evidence was thinner than many public claims suggest. A few outcomes showed signals, especially in cannabis use disorder, sleep-time outcomes in insomnia, tic severity, and autism-related measures, but much of the literature remained low certainty and short-term. This physician-guided review explains what the paper actually found, what it did not test, and how to think about the gap between clinical enthusiasm and evidence quality.
Pilot study on cannabis-induced alterations in platelet function: implications for transfusion medicine.
Platelet transfusions are essential in the management of thrombocytopenia, bleeding disorders, and hematologic malignancies. With cannabis use rising worldwi…
Taurine attenuates lipid accumulation via the eCB-CB1 axis: evidence from adipose metabolomics in HFD-fed mice and 3D adipocyte spheroids.
Obesity, driven by adipose tissue dysfunction, is a major global health challenge and a key contributor to metabolic disorders. Although taurine shows anti-o…
CED Regulatory Digest, Since Last Digest, 2 items
Digest covering 2 recent regulatory items.
Cannabis Wellness Frontiers: 6 Emerging Areas Worth Watching, and What the Evidence Actually Shows
Cannabis research keeps expanding, but not every promising idea deserves the same level of confidence. This physician-guided review explores six emerging cannabis wellness frontiers, including wound healing, endometriosis, trauma, brain injury recovery, menopause, intimacy, and creativity, with clear boundaries around what the evidence does and does not show
CED Regulatory Digest, Since Last Digest, 14 items
Digest covering 14 recent regulatory items.